Sustained Response to Brigatinib in an Aggressive Relapsing Atypical Pituicytoma With ELM4-ALK Fusion
JCO Precis Oncol
.
2024 Nov:8:e2400381.
doi: 10.1200/PO-24-00381.
Epub 2024 Nov 22.
Authors
Pierre-Olivier Moser
1
,
Valérie Rigau
2
3
,
Catherine Goze
3
4
,
Isabelle Ringeard
5
,
Valentin Favier
6
,
Amélie Darlix
3
7
,
Julien Boetto
1
3
Affiliations
1
Department of Neurosurgery, Gui-De-Chauliac Hospital, Montpellier University Medical Center, Montpellier, France.
2
Department of Pathology, Gui-De-Chauliac Hospital, Montpellier University Medical Center, Montpellier, France.
3
Institute of Functional Genomics IGF, University of Montpellier, CNRS, INSERM, Montpellier, France.
4
Laboratory of Solid Tumors Biology, Arnaud de Villeneuve Hospital, Montpellier University Medical Center, Montpellier, France.
5
Department of Endocrinology, Lapeyronie Hospital, Montpellier University Medical Center, Montpellier, France.
6
Department of ENT, Gui-De-Chauliac Hospital, Montpellier University Medical Center, Montpellier, France.
7
Department of Medical Oncology, Institut Régional du Cancer de Montpellier, University of Montpellier, Montpellier, France.
PMID:
39576952
PMCID:
PMC11608595
(available on
2025-11-22
)
DOI:
10.1200/PO-24-00381
No abstract available